Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24-week real-world case series.

Takahashi Y, Hagino T, Saeki H, Fujimoto E, Kanda N

Open source

DOI
10.1111/jdv.70218
Published
2026 Jul
Container
Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jdv.70218,
  title = {Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24-week real-world case series.},
  author = {Takahashi Y and Hagino T and Saeki H and Fujimoto E and Kanda N},
  year = {2026},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.70218},
  url = {https://doi.org/10.1111/jdv.70218}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24-week real-world case series.
AU  - Takahashi Y
AU  - Hagino T
AU  - Saeki H
AU  - Fujimoto E
AU  - Kanda N
PY  - 2026
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.70218
UR  - https://doi.org/10.1111/jdv.70218
ER  - 

APA

Y, T., T, H., H, S., E, F., & N, K. (2026). Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24-week real-world case series.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70218

Source records